WELLINGTON, Fla., Jan. 10 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.U) (http://www.QuantumMD.com) today announced that it has been notified by Paulson Investment Company, a wholly owned subsidiary of Paulson Capital Corp. (Nasdaq: PLCC) and the lead underwriter for the December 2007 public offering, that beginning Monday, January 14, 2008, the Company units will separate into its individual component parts; three shares of common stock, two Class A warrants and two Class B warrants. The units, trading under the symbol QGP.U, will cease to trade as of the close of business on Friday, January 11, 2008. The separation of the units will be voluntary from Monday, January 14, 2008 to Wednesday, January 16, 2008.
At the open of the market on Monday, January 14, 2008, unit holders may separately trade the common stock, Class A warrants and Class B warrants included in such units. The symbols for the common stock, Class A warrants and Class B warrants are QGP, QGP.WS.A and QGP.WS.B, respectively.
About the Company
The Quantum Group, Inc. is a Florida-based organization. The Company builds and manages healthcare systems and offers consulting and outsourcing services that will be leveraged by leading-edge technology to the nation's largest and fastest growing industry- healthcare.
The Company is engaged in the development and execution of a series of innovative technology initiatives designed to make Quantum one of the state's leading providers of business solutions for the healthcare industry. Through its growing number of nearly 1,600 contracted physicians and managed care relationships in the state of Florida, the Company believes it is positioned to bring increased efficiencies to the Florida healthcare industry.
Certain statements contained in this news release, which are not based
on historical facts, are forward-looking statements as the term is defined
in the Private Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the respective
company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K
filings (and amendments thereto) that may cause actual results to
materially differ from projections. Forward-looking statements can be
identified by the use of words such as "expects," "plans," "will," "may,"
"anticipates," "believes," "should," "intends," "estimates" and other words
of similar meaning. These statements are subject to risks and uncertainties
that cannot be predicted or quantified and, consequently, actual results
may differ materially from those expressed or implied by these
forward-looking statements. Such risk factors include, without limitation,
the ability of the Company to properly execute its business model, to raise
substantial and immediate additional capital to implement its business
model, to attract and retain executive, management and operational
personnel, to negotiate favorable current debt and future capital raises,
to negotiate favorable agreements with a diversified provider base and to
continue to supply the services needed by its HMO clients as well physician
clients. The Company does not undertake any obligation to publicly update
any forward-looking statements. As a result, investors should not place
undue reliance on these forward-looking statements.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group, LLC
Daniel Conway, Chief Strategist
407.585.1080 or via email at Quantum@efcg.net
Vice President, Corporate Communications
The Quantum Group, Inc.
|SOURCE The Quantum Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved